Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

SZSE:002993
SZSE:002993Tech

Global Dividend Stocks To Consider In January 2026

As global markets navigate a mixed landscape with small-cap and value stocks leading the charge, investors are keeping a close eye on inflation trends and geopolitical developments. Amidst this backdrop, dividend stocks continue to attract attention for their potential to provide steady income streams; selecting companies with strong fundamentals and consistent dividend histories can be particularly appealing in such dynamic market conditions.
NasdaqGS:HBAN
NasdaqGS:HBANBanks

A Look At Huntington Bancshares (HBAN) Valuation After Q4 Miss And Acquisition Driven Growth Outlook

Huntington Bancshares (HBAN) is back in focus after fourth quarter results came in slightly below analyst expectations, while management paired that short term disappointment with upbeat guidance tied to recent acquisitions. See our latest analysis for Huntington Bancshares. The mixed reaction to earnings and acquisition updates has fed into recent trading, with a 1-day share price return showing a 6.02% decline and a softer 7-day share price return showing a 2.11% decline. However, the...
NYSE:BLDR
NYSE:BLDRBuilding

A Look At Builders FirstSource (BLDR) Valuation As Optimism Rises On Housing Data And Rate Cut Hopes

Builders FirstSource (BLDR) is back in focus as optimism around its outlook picks up, with better housing data and potential interest rate easing supporting a rebound in sentiment despite ongoing margin and housing headwinds. See our latest analysis for Builders FirstSource. At a recent share price of $125.25, Builders FirstSource has seen a 21.96% 1 month share price return and a 19.71% year to date share price return. However, its 1 year total shareholder return shows a 25.50% decline...
ASX:VEA
ASX:VEAOil and Gas

Assessing Viva Energy Group’s Valuation After Leadership Transition And New Board Appointments

Leadership changes at Viva Energy Viva Energy Group (ASX:VEA) has announced a planned board transition, with long-serving Chair the Honourable Robert Hill AC retiring in March 2026 and current director Dr Sarah Ryan FTSE appointed as Chair elect. Dr Ryan, who joined the Viva Energy board in 2018, brings more than 30 years of global energy sector and investment management experience. Incoming Independent Non Executive Director Alistair Bell adds extensive commercial and financial leadership...
SEHK:2269
SEHK:2269Life Sciences

New UK MHRA Certifications and PatroLab Platform Might Change The Case For Investing In WuXi Biologics (Cayman) (SEHK:2269)

WuXi Biologics recently announced that its Wuxi Drug Product Facility 5 and Drug Product Packaging Center received UK MHRA GMP certifications for commercial ophthalmic biologic manufacturing, alongside the launch of its PatroLabTM digital twin platform for real-time bioprocess monitoring and control. Together, these developments highlight WuXi Biologics’ growing role as a globally compliant manufacturer that is integrating advanced digital technologies to enhance biologics quality and...
NYSE:EPAM
NYSE:EPAMIT

EPAM Systems Deepens Enterprise AI Push With Cursor And Google Cloud Agents

EPAM Systems (NYSE:EPAM) has entered into a partnership with Cursor to expand its enterprise generative AI capabilities. The company has introduced several new AI agents on Google Cloud Marketplace as part of this effort. These moves are aimed at supporting enterprise clients that are adopting generative AI solutions. EPAM Systems is leaning into AI driven services at a time when many enterprises are experimenting with generative tools and automation. The stock last closed at $219.05, with...
ENXTPA:UBI
ENXTPA:UBIEntertainment

Ubisoft Overhaul Reshapes Game Portfolio And Undervalued Investment Case

Ubisoft Entertainment (ENXTPA:UBI) has announced a broad overhaul of its organization and game portfolio. The plan includes cancelling and delaying multiple titles, closing certain studios, and restructuring operations across the group. The company is reshaping its creative leadership and refocusing resources on a narrower set of projects. Ubisoft, known for franchises such as Assassin’s Creed and Far Cry, is a major European publisher in an industry where development costs, competition,...
NasdaqGS:WMT
NasdaqGS:WMTConsumer Retailing

Evaluating Walmart (WMT) After Nasdaq-100 Inclusion And Tech Focused Growth Moves

Walmart (WMT) is back in focus after its addition to the Nasdaq-100 Index, leadership moves toward tech and e-commerce, and the launch of a Premium Musical Instrument Shop on Walmart Marketplace. See our latest analysis for Walmart. Those tech focused moves and category expansions sit against a share price of $117.83, with a 30 day share price return of 5.57% and a 90 day share price return of 10.98%. The 1 year total shareholder return of 25.54% and very large 3 year and 5 year total...
NasdaqGS:LECO
NasdaqGS:LECOMachinery

Lincoln Electric Quality Screen Win Puts Valuation And Debt In Focus

Lincoln Electric Holdings (NasdaqGS:LECO) was recently recognized for its financial health and competitive advantages after passing a respected quality investing screen. The screen highlights companies with resilient balance sheets, consistent execution, and durable business models. This recognition singles out Lincoln Electric’s long term positioning in welding, cutting, and joining solutions as especially robust. Lincoln Electric focuses on arc welding equipment, consumables, and...
NasdaqGS:UTHR
NasdaqGS:UTHRBiotechs

Is United Therapeutics (UTHR) Attractive After Recent Pullback And Strong Multi Year Gains?

If you are trying to work out whether United Therapeutics at about US$472 per share looks expensive or reasonable, you are in the right place. The stock has been flat over the last 7 days, with a 7.5% decline over the past month and a 5.0% decline year to date, set against a 26.9% return over 1 year, 78.7% over 3 years and 187.2% over 5 years. Recent coverage around United Therapeutics has focused on how the company is positioned within the pharmaceuticals and biotech space and how investors...
NasdaqGS:FLYW
NasdaqGS:FLYWDiversified Financial

Does Flywire’s Leadership Shift Toward AI-led Education Products Reframe The Bull Case For FLYW?

On January 13, 2026, Flywire announced a leadership restructuring in which longtime Chief Technology Officer David King will become Chief Product Officer & Co-President of Global Education, while the company searches for a new CTO to oversee its global payments and software platform. This shift places King’s education software expertise at the center of Flywire’s product strategy across all verticals, signaling a reinforced emphasis on software innovation and AI-enabled workflows for its...
NYSE:BMY
NYSE:BMYPharmaceuticals

Did AI Lung Imaging And New HCM Data Just Shift Bristol Myers Squibb’s (BMY) Investment Narrative?

Bristol Myers Squibb recently entered a global licensing deal with Janux Therapeutics to co-develop a tumor-activated solid tumor therapy and announced a collaboration with Microsoft to deploy FDA-cleared AI radiology algorithms for earlier lung cancer detection, while also reporting positive Phase 3 SCOUT-HCM results for Camzyos in adolescents with obstructive hypertrophic cardiomyopathy. Taken together, these moves highlight how Bristol Myers Squibb is pairing advanced oncology drug...
NasdaqGS:OKTA
NasdaqGS:OKTAIT

How Okta’s India AI Identity Push At Okta (OKTA) Has Changed Its Investment Story

Okta recently reinforced its commitment to India by launching in-country Okta Platform tenants hosted on AWS, offering local data storage, enhanced disaster recovery, and support for compliance with the DPDP Act and sector-specific regulations across highly regulated industries. By extending its identity security fabric to cover both human and AI agents within India, Okta is directly targeting the growing governance gap as organizations adopt AI faster than they develop controls for...
NYSE:SPXC
NYSE:SPXCMachinery

Is It Too Late To Consider SPX Technologies (SPXC) After A 5-Year 297% Rally?

If you are wondering whether SPX Technologies at around US$217 a share still offers value, you are not alone, and that is exactly what this article aims to unpack. The share price sits at US$217.13, with returns of 1.6% over the past week, 5.7% over the last 30 days, 6.8% year to date, 40.7% over 1 year, 202.2% over 3 years, and 297.1% over 5 years, which naturally raises questions about what is already priced in and what might come next. Recent attention on SPX Technologies has centered on...
NYSE:BJ
NYSE:BJConsumer Retailing

A Look At BJ's Wholesale Club (BJ) Valuation As Shares Trade Near $96 And Fair Value Seen At $109.26

BJ's Wholesale Club Holdings (BJ) is back on investors’ radar after a recent move in the share price, with the stock closing at $96.00 and showing mixed returns across different time frames. See our latest analysis for BJ's Wholesale Club Holdings. The recent 1 day share price return of 1.43% and 90 day share price return of 4.61% sit alongside a 1 year total shareholder return decline of 1.07% and a 5 year total shareholder return of 119.93%. This suggests that longer term holders have still...
NYSE:RSG
NYSE:RSGCommercial Services

Assessing Republic Services (RSG) Valuation After Mixed Returns And Premium P/E Rating

Why Republic Services (RSG) is on investors’ radar Republic Services (RSG) has drawn interest after its shares closed at $215.75, with recent returns mixed across shorter and longer periods. This has prompted investors to reassess what they are paying for its business performance. See our latest analysis for Republic Services. Recent trading has been relatively firm, with a 1 day share price return of 0.68% and a 7 day share price return of 2.35%. The 90 day share price return of 3.29%...
NYSE:HUM
NYSE:HUMHealthcare

Humana (HUM) Valuation Check As Shares Lag And Fair Value Signals Point To Modest Undervaluation

Event context and recent stock performance Humana (HUM) has drawn investor attention after a mixed stretch in its share performance, with the stock down about 8% over the past year but slightly positive year to date. See our latest analysis for Humana. At a share price of US$266.29, Humana has seen pressure in the very short term, with a 1 day share price return of 1.62% decline and a 7 day share price return of 6.22% decline. Its 1 year total shareholder return of 8.10% decline and 3 year...
ASX:COL
ASX:COLConsumer Retailing

A Look At Coles Group’s Valuation As Goldman Sachs Starts Coverage With A Neutral Rating

Coverage initiation puts Coles Group (ASX:COL) in focus Goldman Sachs has initiated coverage on Coles Group (ASX:COL) with a Neutral rating, citing regulatory risks from federal court proceedings on discounting practices and highlighting margin pressure from higher wage costs and increased scrutiny. See our latest analysis for Coles Group. Coles Group’s 1 year total shareholder return of 12.61% and 3 year total shareholder return of 33.89% sit against weaker recent momentum, with a 90 day...
SEHK:992
SEHK:992Tech

Will New AI Retail And Classroom Tools Recast Lenovo Group's (SEHK:992) Integrated Ecosystem Narrative

Lenovo announced new AI-powered Smart Store Services and AI Retail Assistants for retailers, alongside refreshed Chromebook and device orchestration solutions for education, with plans to showcase them at Bett UK 2026 in London. By embedding AI across both classroom devices and in-store retail operations, Lenovo is positioning its technology as core infrastructure for everyday learning and shopping experiences. We’ll now explore how these AI-driven retail and education offerings shape...
NasdaqGS:AAPL
NasdaqGS:AAPLTech

Is Apple (AAPL) Starting To Look Expensive After Recent Share Price Weakness?

If you are wondering whether Apple at around US$248 per share is still a fair deal or starting to look stretched, you are not alone. The stock is down 3.8% over the last week and 8.8% over the last month, although it is still up 11.5% over the past year and 75.1% over three years, with a 5 year return of 86.1%. Recent headlines around Apple have continued to focus on its position as a major US tech company, with recurring attention on its products, ecosystem and role in global equity...
NasdaqGS:KMB
NasdaqGS:KMBHousehold Products

Kimberly Clark (KMB) Valuation Check After Recent Share Price Weakness And Kenvue Deal Expectations

Why Kimberly-Clark Stock Is On Investors’ Radar Today Kimberly-Clark (KMB) has drawn fresh attention after recent share moves, with the stock up about 2% over the past month but showing a roughly 14% decline over the past 3 months. See our latest analysis for Kimberly-Clark. At around US$102 per share, Kimberly-Clark has seen short term share price strength, with a 2.08% 30 day share price return. However, that sits against a 14.08% 90 day share price decline and a 16.26% 1 year total...